Sponsored by:

Nuclear Medicine: Page 326

SNM explores feasibility of U.S. medical isotope source
By Wayne Forrest
Last week's announcement by Atomic Energy of Canada (AECL) to discontinue the development of two new nuclear reactors for producing medical isotopes has the nuclear medicine community scrambling to develop alternative sources. One option is creating a source for medical isotope production within the U.S., according to the president of the SNM.
May 21, 2008
2008 05 21 15 40 27 706
Canadian government to stop development of Maple reactors
By AuntMinnie.com staff writers
Atomic Energy of Canada (AECL) has announced that it will discontinue development of two Maple medical-isotope-dedicated reactors at Chalk River Laboratories in Ontario, effective immediately.
May 15, 2008
PETNet gets U.K. FDG license
By AuntMinnie.com staff writers
Siemens Healthcare said that its PETNet Solutions division has received a full Marketing Authorization and Manufacturer's/Importer's (MIA) license to produce and distribute its FDG biomarker from its Nottingham City Hospital site.
May 11, 2008
Revenues slip, loss posted in Draxis' Q1
By AuntMinnie.com staff writers
Lower sales of sterile products, the negative impact of a stronger Canadian dollar, and costs related to the potential sale of the company combined to stymie growth at Draxis Health in the first quarter.
May 8, 2008
Covidien posts strong Q2
By AuntMinnie.com staff writers
Double-digit sales gains in its medical devices and imaging divisions helped drive a 10% increase in second-quarter net sales for Covidien.
May 6, 2008
Neoprobe inks UCSD deal
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has signed a technology licensing agreement with the University of California, San Diego (UCSD).
May 5, 2008
Dilon nets CE Mark
By AuntMinnie.com staff writers
Scintimammography developer Dilon Technologies has received the European CE Mark for its Dilon 6800 gamma camera.
May 5, 2008
Whole-body PET better for palpable breast cancer
By Barbara Boughton
Whole-body FDG-PET has high sensitivity for detecting palpable breast cancer, but is less effective in detecting metastatic disease in axillary lymph nodes, according to researchers from Japan. The researchers evaluated whole-body FDG-PET in 80 women who had palpable breast tumors or positive uptake in whole-body PET scans, and presented their study results at the 2008 American Association for Cancer Research (AACR) meeting in San Diego.
May 1, 2008
Neoprobe posts Q1 revenue gains
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe announced revenue increases and a decreased net loss for its first quarter of 2008 (end-March 31).
April 30, 2008
PET drives growth in nuclear medicine market
By AuntMinnie.com staff writers
The popularity of PET procedures is driving overall growth in the nuclear medicine market, but it will adversely affect the sales of conventional gamma/scintillation cameras in the coming years.
April 29, 2008
Digirad signs deal with U. of Chicago
By AuntMinnie.com staff writers
Nuclear medicine firm Digirad of Poway, CA, has signed an agreement with the University of Chicago Medical Center to provide cardiac diagnostic services to Chicago-area physicians and patients.
April 28, 2008
NMPI contemplates sale
By AuntMinnie.com staff writers
Mobile imaging firm Nuclear Medicine Professionals (NMPI) reported record revenues for its first quarter 2008, leading its managing partners to consider plans for the sale of the company.
April 24, 2008
Previous Page
Page 326 of 440
Next Page